ANP T2238C, C-664G gene polymorphism and coronary heart diseasein Chinese population

Abstract

The association between atrial natriuretic peptide (ANP) polymorphism and coronary heart disease (CHD) was studied in Chinese population. The genotypes of ANP T2238C and ANP C-664G were detected by polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP) methods in 158 consecutive CHD patients and 165 controls. It was found that the distribution of A2A2 genotype in CHD group was significantly higher than that in control group (P<0.05). Stepwise Logistic regression analysis revealed that male, smoking, history of hypertension, history of diabetes, family history of hypertension, high level of serum cholesterol, and ANP T2238C polymorphism were the possible risk factors in patients with CHD (P<0.05). However, there was no significant difference between the patients with CHD and the control group in the distribution of ANP C-664G polymorphism (P>0.05). The results suggest that A2A2 T2238C genotype could be one of the risk factors for CHD (P<0.05, OR: 1.80, 95 % CI: 1.03–3.15).

Keywords

coronary heart disease / atrial natriuretic peptide / polymorphism

References

[1] ScottM., GaryJ., MichaelH., et al.. Primary prevention of coronary heart disease: Guidance from framingham. Circulation, 1998, 97: 1876-1890

[2] NishikimiT., MoriY., IshimuraK., et al.. Association of plasma atrial natriuretic peptide, N-terminal proatrial natriuretic peptide, and brain natriuretic peptide levels with coronary artery stenosis in patients with normal left ventricular systolic function. Am J Med., 2004, 116(8): 517-523

[3] TakagiG., KiuchiK., EndoT., et al.. Alpha-human atrial natriuretic peptide, carperitide, reduces infarct size but not arrhythmias after coronary occlusion/reperfusion in dogs. J Cardiovasc Pharmacol, 2000, 36(1): 22-30

[4] KatoN., SugiyamaT., MoritaH., et al.. Genetic analysis of the atrial natriuretic peptide gen in essential hypertension. Clin Sci, 2000, 98: 251-258

[5] MasharaniU., NakashimaP. F., LimD. W., et al.. NsiI and ScaI restriction fragment length polymorphisms at the atrial natriuretic peptide (ANP) gene locus. Hum Genet, 1998, 80: 307-312

[6] GruchalaM., CiecwierzD., WasagB., et al.. Association of the ScaI atrial natriuretic peptide gene polymorphism with nonfatal myocardial infarction and extent of coronary artery disease. Am Heart J, 2003, 145(1): 125-131